286
Views
13
CrossRef citations to date
0
Altmetric
SHORT REPORT

A pilot trial with clenbuterol in amyotrophic lateral sclerosis

, , , , , , , & show all
Pages 252-254 | Received 15 Sep 2005, Accepted 24 Jan 2006, Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

. (2021) Theme 09 - CLINICAL TRIALS AND TRIAL DESIGN. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:sup2, pages 150-173.
Read now

Articles from other publishers (12)

Xiaoyan Li, Dwight D. Koeberl, Michael W. Lutz & Richard Bedlack. (2023) Clenbuterol Treatment Is Safe and Associated With Slowed Disease Progression in a Small Open-Label Trial in Patients With Amyotrophic Lateral Sclerosis. Journal of Clinical Neuromuscular Disease 24:4, pages 214-221.
Crossref
Caterina Marchioretti, Emanuela Zuccaro, Udai Bhan Pandey, Jessica Rosati, Manuela Basso & Maria Pennuto. (2022) Skeletal Muscle Pathogenesis in Polyglutamine Diseases. Cells 11:13, pages 2105.
Crossref
Monika Sharma & Patrick M. Flood. 2019. Neuroprotection. Neuroprotection.
Carmelo Milioto, Adriana Malena, Eleonora Maino, Maria J. Polanco, Caterina Marchioretti, Doriana Borgia, Marcelo Gomes Pereira, Bert Blaauw, Andrew P. Lieberman, Roberta Venturini, Mario Plebani, Fabio Sambataro, Lodovica Vergani, Elena Pegoraro, Gianni Sorarù & Maria Pennuto. (2017) Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes. Scientific Reports 7:1.
Crossref
Raymond T. Bartus, Alexandre Bétourné, Anthony Basile, Bethany L. Peterson, Jonathan Glass & Nicholas M. Boulis. (2016) β 2 -Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS). Neurobiology of Disease 85, pages 11-24.
Crossref
Benjamin L. Farah, Lauran Madden, Songtao Li, Sierra Nance, Andrew Bird, Nenad Bursac, Paul M. Yen, Sarah P. Young & Dwight D. Koeberl. (2014) Adjunctive β 2 ‐agonist treatment reduces glycogen independently of receptor‐mediated acid α‐glucosidase uptake in the limb muscles of mice with Pompe disease . The FASEB Journal 28:5, pages 2272-2280.
Crossref
Songtao Li, Baodong Sun, Mats I. Nilsson, Andrew Bird, Mark A. Tarnopolsky, Beth L. Thurberg, Deeksha Bali & Dwight D. Koeberl. (2012) Adjunctive β2‐agonists reverse neuromuscular involvement in murine Pompe disease. The FASEB Journal 27:1, pages 34-44.
Crossref
Zhan-Miao Yi, Fang Liu, Suo-Di Zhai, Jerry Belsh, Si-Yan Zhan & Philip Schiffman. (2012) Pharmacological interventions for improving respiratory function in amyotrophic lateral sclerosis. Cochrane Database of Systematic Reviews.
Crossref
Renske I Wadman, Wendy MJ Bosboom, W Ludo van der Pol, Leonard H van den Berg, John HJ Wokke, Susan T Iannaccone & Alexander FJE Vrancken. (2012) Drug treatment for spinal muscular atrophy types II and III. Cochrane Database of Systematic Reviews.
Crossref
Renske I Wadman, Wendy MJ Bosboom, Leonard H van den Berg, John HJ Wokke, Susan T Iannaccone & Alexander FJE Vrancken. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Wendy MJ Bosboom, Alexander FJE Vrancken, Leonard H van den Berg, John HJ Wokke & Susan T Iannaccone. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Gordon S. Lynch & James G. Ryall. (2008) Role of β-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease. Physiological Reviews 88:2, pages 729-767.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.